Key result
Fasting hyperglycaemia linked to ~8-fold greater risk of in-hospital acute LVF after AMI.
Why the study?
Patients with recent myocardial infarction have an increased incidence of impaired fasting glucose and new-onset diabetes, with elevated fasting glucose linked to increased morbidity and mortality.
Does fasting hyperglycaemia predict worse outcomes in patients with acute myocardial infarction?
Cohort (n=102)
No
Does fasting hyperglycaemia predict worse outcomes in patients with acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Fasting hyperglycaemia is a significant predictor of in-hospital heart failure and 30-day cardiovascular mortality following a first acute myocardial infarction.
Background: Patients with recent myocardial infarction have an increased incidence of impaired fasting glucose (IFG) and new-onset diabetes. There is a clear relationship between elevated fasting glucose during acute myocardial infarction and increased mortality and morbidity risk. Objective: To find out the impact of fasting glycaemia as a predictor of outcome of patients with acute myocardial infarction. Methods: A total of 102 patients with acute myocardial infarction of first attack were selected according to inclusion and exclusion criteria. Fifty-one patients with acute myocardial infarction having fasting hyperglycaemia were enrolled as case group and another 51 patients with acute myocardial infarctions having fasting euglycaemia were enrolled as control group. Results: Among the diabetic patients, acute left ventricular failure (ALVF) developed in 22 (68.8% ), arrhythmias in 5 (16.6%) and cardiovascular mortality in 8 (25.0% ) patients ; it was 7 (36.8%), 4 (21.1 %) and 4 (21.1 %) respectively in IFG patients; and 7 (13.7%) ,4 (7.8%) and 2 (3.9%) respectively in euglycaemia patients. Acute left ventricular failme and 30 days CV mortality significantly differed among the groups (p<0.001 and p=0.015 respectively). But no significant difference in arrhythmias (p=-0.284). Conclusions: The patients of impaired fasting glucose (IFG) and diabetes mellitus both were predictor for in hospital heart failure (ALVF) and 30-day cardiovascular mortality as compared to euglycaemia.
No takes yet. Share an insight, caveat, or question.
Shofiullah et al. (2016) conducted a cohort in Acute myocardial infarction (n=102). Fasting hyperglycaemia vs. Fasting euglycaemia was evaluated on In-hospital acute left ventricular failure (OR 8.286, 95% CI 3.137-21.883, p=<0.001). Fasting hyperglycaemia increased the risk of developing in-hospital acute left ventricular failure compared to euglycaemia in patients with acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: